Search News
| 89.83 Delayed Data As of Sep 21 |  -0.23 / -0.26%Today’s Change | 62.79 Today|||52-Week Range 93.67 | +24.69% Year-to-Date |
| Eli Lilly Prices Animal Health Unit IPO at $24 Per Share Sep 20 / Zacks.com - Paid Partner Content | Top Analyst Reports for Berkshire Hathaway, Coca-Cola & Disney Sep 10 / Zacks.com - Paid Partner Content |
| The Zacks Analyst Blog Highlights: Berkshire Hathaway, Coca-Cola, Disney, BHP and Zoe... Sep 11 / Zacks.com - Paid Partner Content |
| Previous close | 90.06 |
| Today’s open | 90.03 |
| Day’s range | 89.79 - 90.93 |
| Volume | 3,448,374 |
| Average volume (3 months) | 2,390,105 |
| Market cap | $43.3B |
| Earnings growth (last year) | +6.06% |
| Earnings growth (this year) | +28.23% |
| Earnings growth (next 5 years) | +15.30% |
| Revenue growth (last year) | +8.57% |
| P/E ratio | 39.4 |
| Price/Sales | 6.69 |
| Price/Book | 24.67 |
| Today’s change | Today’s % change | |
|---|---|---|
| REGNRegeneron Pharmaceut... | +3.03 | +0.78% |
| BAXBaxter International... | -0.32 | -0.41% |
| VRTXVertex Pharmaceutica... | -0.44 | -0.24% |
| SHPGShire | -1.60 | -0.89% |
| Next reporting date | November 6, 2018 |
| EPS forecast (this quarter) | $0.77 |
| Annual revenue (last year) | $5.3B |
| Annual profit (last year) | $864.0M |
| Net profit margin | 16.28% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
Chief Executive Officer & Director Juan Ramón Alaix |
Executive Vice President & President-US Operations Kristin C. Peck |
Corporate headquarters New Jersey, New Jersey |
